Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 6-7, Juin–Juillet 2002
Page(s) 737 - 743
Section M/S Revues : Articles de Synthèse
DOI https://doi.org/10.1051/medsci/20021867737
Publié en ligne 15 juin 2002
  1. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (suppl 5) : S4–9. [Google Scholar]
  2. American Psychiatric Association. Manuel diagnostique et statistique des troubles mentaux. DSM-III-R. Paris : Masson, 1989. [Google Scholar]
  3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer’s disease. Neurology 1984; 34 : 939–44. [Google Scholar]
  4. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54 (suppl 5) : S10–5. [Google Scholar]
  5. Letenneur L, Commenges D, Dartigues JF, Barberger-Gateau P. Incidence of dementia and Alzheimer’s disease in elderly community residents of south-western France. Int J Epidemiol 1994; 23 : 1256–61. [Google Scholar]
  6. Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF. Are sex and educational level independent predictors of dementia and Alzheimer’s disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatr 1999; 66 : 177–83. [Google Scholar]
  7. Edland SD, Rocca W, Petersen RC, Cha RH, Kokmen E. The incidence of Alzheimer’s disease does not vary by gender in Rochester, MN. Neurobiol Aging 2000; 21 : S203. [Google Scholar]
  8. Breitner JCS, Folstein MF, Murphy EA. Familial agregation in Alzheimer dementia. J Psychiatr Res 1986; 20 : 31–43. [Google Scholar]
  9. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer’s disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999; 52 : 78–84. [Google Scholar]
  10. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer Disease. Meta analysis consortium. JAMA 1997; 278 : 1349–58. [Google Scholar]
  11. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer’s disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151 : 390–6. [Google Scholar]
  12. Graves AB, Mortimer JA, Bowen JD, et al. Head circumference and incident Alzheimer’s disease -Modification by apolipoprotein E. Neurology 2001; 57 : 1453–60. [Google Scholar]
  13. Schofield P, Logroscino G, Andrews H, Albert S, Stern Y. An association between head circonference and Alzheimer’disease in a population-based study of aging and dementia. Neurology 1997; 49 : 30–7. [Google Scholar]
  14. Fabrigoule C, Letenneur L, Dartigues JF, Zarrouk M, Commenges D, Barberger-Gateau P. Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 1995; 43 : 485–90. [Google Scholar]
  15. Helmer C, Damon D, Letenneur L, et al. Marital status and risk of Alzheimer’s disease : a French population-based cohort study. Neurology 1999; 53 : 1953–8. [Google Scholar]
  16. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 2000; 355 : 1315–9. [Google Scholar]
  17. Mayeux R, Ottman R, Tang M, et al. Genetic susceptibility and head injury as risk factors for Alzheimer’s disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993; 33 : 494–501. [Google Scholar]
  18. Li G, Shen Y, Li Y, Chen C, Zhau Y, Silverman J. A case-control study of Alzheimer’s disease in China. Neurology 1992; 42 : 1481–8. [Google Scholar]
  19. Mehta K, Ott A, Kalmijn S, et al. Head trauma and risk of dementia and Alzheimer’s disease: the Rotterdam Study. Neurology 2000; 53 : 1959–62. [Google Scholar]
  20. Jorm AF. Is depression a risk factor for dementia or cognitive decline : a review. Gerontology 2000; 46 : 219–27. [Google Scholar]
  21. Orgogozo JM, Dartigues JF, Lafont S, et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol 1997; 153 : 185–92. [Google Scholar]
  22. Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the Paquid study. Am J Epidemiol 1998; 148 : 298–306. [Google Scholar]
  23. Ruitenberg A, Swieten JC, Hofman A, Breteler MMB. Alcohol consumption and risk of dementia: results from the Rotterdam study. Neurobiol Aging 2000; 21 : 1129. [Google Scholar]
  24. Kalmijn S, Launer LJ, Ott A, Wittemen JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997; 42 : 776–82. [Google Scholar]
  25. Martyn CN, Barker JP, Osmond C, Harris EC, Edwarson JA, Lacey RF. Geographical relation between Alzheimer’s disease and aluminium in drinking water. Lancet 1989; 14 : 59–62. [Google Scholar]
  26. Martyn C, Coggon D, Lacey R. Aluminium concentrations in drinking water and risk of Alzheimer’s disease. Epidemiology 1997; 8 : 281–6. [Google Scholar]
  27. Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. Relation between aluminum concentrations in drinking water and Alzheimer’s disease: An 8-year followup study. Am J Epidemiol 2000; 152 : 59–66. [Google Scholar]
  28. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 1994; 140 : 256–61. [Google Scholar]
  29. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore longitudinal study of aging. Neurology 1997; 48 : 1517–21. [Google Scholar]
  30. Breitner JCS, Zandi PP. Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer’s disease? N Engl J Med 2001; 345 : 1567–8. [Google Scholar]
  31. Intveld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 2001; 345 : 1515–21. [Google Scholar]
  32. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 1997; 349 : 151–4. [Google Scholar]
  33. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352 : 1347–51. [Google Scholar]
  34. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologica 1996; 39 : 1392–7. [Google Scholar]
  35. Vanduijn C, Stijnen T, Hofman A. Risk factors for Alzheimer’s disease : overview of the Eurodem collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20 (suppl 2) : S4–12. [Google Scholar]
  36. Merchant C, Tang M, Albert S, Manly J, Stern Y, Mayeux R .The influence of smoking on the risk of Alzheimer’s disease. Neurology 1999; 52 : 1408–12. [Google Scholar]
  37. Bonarek M, Barberger-Gateau P, Letenneur L, et al. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the Paquid study. Neuroepidemiology 2000; 19 : 141–8. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.